TipRanks
pc:leyde

Leyden Laboratories BV

Therapeutics
Leyden Laboratories B.V. is a clinical-stage biotechnology company based in the Netherlands, specializing in the development of nasal sprays designed to provide broad protection against respiratory viruses. Utilizing its Mucosal Protection Platform, Leyden Labs aims to deliver antibody-based nasal sprays that offer immediate protection by targeting the respiratory mucosa, effectively blocking viruses at their point of entry. This innovative approach is particularly beneficial for vulnerable populations, such as the elderly and immunocompromised, and remains effective even as viruses mutate. The company's lead product candidate, CR9114, is a human monoclonal antibody licensed from Janssen Pharmaceuticals, demonstrating promising protection against influenza in preclinical models.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$30M
Total Amount Raised$30M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$30M
Latest Funding Amount$30M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Investment
$30.00M
―

Investors

Investor Name
Funding Round
European Innovation Council Fund
Investment
Invest-NL
Investment

Similar Companies

A snapshot of private companies similar to Leyden Laboratories BV, helping you discover and navigate related company profiles.
PC:BIOLEBiolevate
PC:AVANZAvanzanite Bioscience
PC:ARCTIArctic Therapeutics
PC:MCAREM2care

Related News and Analysis

Mysten Labs Unveils Verifiable Agent Arbiter to Audit Enterprise AI on Sui and Walrus

Mysten Labs Unveils Verifiable Agent Arbiter to Audit Enterprise AI on Sui and Walrus

New updates have been reported about Mysten Labs. Mysten Labs has launched Verifiable Agent Arbiter (VAA), a new...
48m ago
MYSTE
DeepL Voice Wins Fast Company Innovation Nod as New Voice Models Target Enterprise Use

DeepL Voice Wins Fast Company Innovation Nod as New Voice Models Target Enterprise Use

New updates have been reported about DeepL. DeepL has secured a place on Fast Company’s 2026 Next Big...
48m ago
DEE67
Betterment Launches Unified Managed Accounts to Expand RIA Customization and Tax Efficiency

Betterment Launches Unified Managed Accounts to Expand RIA Customization and Tax Efficiency

New updates have been reported about Betterment. Betterment Advisor Solutions has introduced Unified Managed Accounts (UMAs), positioning the...
1h ago
BET6I
Adonis Showcases RCM Leadership With 2026 RCM25 Awards Program

Adonis Showcases RCM Leadership With 2026 RCM25 Awards Program

New updates have been reported about Adonis. Adonis, a revenue cycle intelligence and automation provider, has expanded its...
1h ago
ADONI
Octane Secures Record $1.4 Billion Forward-Flow Facility to Scale Powersports and OPE Lending

Octane Secures Record $1.4 Billion Forward-Flow Facility to Scale Powersports and OPE Lending

New updates have been reported about Octane. Octane has closed a $1.4 billion forward-flow facility, its largest such...
1h ago
OCTAN
RELEX Solutions Deploys AI-Driven Planning Platform Across Covetrus U.S. Distribution Network

RELEX Solutions Deploys AI-Driven Planning Platform Across Covetrus U.S. Distribution Network

New updates have been reported about RELEX Solutions. RELEX Solutions has implemented its AI-based forecasting and replenishment platform...
1h ago
RELEX
Best Egg Launches Financial Confidence Report to Guide Strategy in Serving Cash‑Strapped Consumers

Best Egg Launches Financial Confidence Report to Guide Strategy in Serving Cash‑Strapped Consumers

New updates have been reported about Best Egg. Best Egg has released its inaugural Financial Confidence Report, using...
1h ago
BESTE
pubX Secures $5M Series A and Acquires Compliant to Scale Agent-to-Agent Ad Infrastructure

pubX Secures $5M Series A and Acquires Compliant to Scale Agent-to-Agent Ad Infrastructure

New updates have been reported about pubX. pubX has raised a $5 million Series A round led by...
2h ago
PUBXX
KymaThera Secures $80 Million Series B to Advance Next-Generation PI3Kα Inhibitor K-1728

KymaThera Secures $80 Million Series B to Advance Next-Generation PI3Kα Inhibitor K-1728

New updates have been reported about KymaThera. KymaThera has raised $80 million in a Series B round led...
2h ago
KYMAT
Pure Launches Mobile App to Scale Peer-to-Peer Precious Metals Trading

Pure Launches Mobile App to Scale Peer-to-Peer Precious Metals Trading

New updates have been reported about Pure. Pure, a Los Angeles-based peer-to-peer marketplace for precious metals and rare...
2h ago
PUREX